Biodexa Pharmaceuticals's market cap is currently $2.89M. The company's EPS TTM is $-49.738; its P/E ratio is ―; Biodexa Pharmaceuticals is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 381.00K	£ 699.00K	£ 578.00K	£ 343.00K	£ 674.00K
Gross Profit	£ -3.69M	£ -4.41M	£ -4.08M	£ -5.72M	£ -7.17M
Operating Income	£ -8.01M	£ -8.93M	£ -7.00M	£ -10.67M	£ -11.32M
EBITDA	£ -7.16M	£ -7.39M	£ -5.66M	£ -22.22M	£ -9.54M
Net Income	£ -7.08M	£ -7.66M	£ -5.46M	£ -22.19M	£ -9.14M
Balance Sheet
Cash & Short-Term Investments	£ 5.97M	£ 2.84M	£ 10.06M	£ 7.55M	£ 10.93M
Total Assets	£ 10.54M	£ 5.53M	£ 12.91M	£ 9.82M	£ 30.89M
Total Debt	£ 464.00K	£ 624.00K	£ 766.00K	£ 260.00K	£ 6.08M
Net Debt	£ -5.51M	£ -2.21M	£ -9.29M	£ -7.29M	£ -4.85M
Total Liabilities	£ 5.86M	£ 2.36M	£ 2.46M	£ 3.10M	£ 11.34M
Stockholders' Equity	£ 4.68M	£ 3.16M	£ 10.45M	£ 6.72M	£ 19.56M
Cash Flow
Free Cash Flow	£ -7.09M	£ -7.11M	£ -6.33M	£ -9.51M	£ -6.81M
Operating Cash Flow	£ -6.83M	£ -7.05M	£ -6.01M	£ -9.30M	£ -6.49M
Investing Cash Flow	£ -265.00K	£ -220.00K	£ -278.00K	£ 2.57M	£ -3.81M
Financing Cash Flow	£ 10.23M	£ 47.00K	£ 8.80M	£ 3.08M	£ 18.73M

Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History

Income Statement >

Biodexa Pharmaceuticals Debt to Assets

Balance Sheet >

Biodexa Pharmaceuticals Cash Flow

Cash Flow >

Biodexa Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing